Four cases with no available material for cytologic evaluation were mutated for KRAS and upon follow-up three were IPMN (two BD-IPMN and one MD-IPMN with moderate dysplasia). Here, KRAS is linked to pancreatic intraductal papillary-mucinous neoplasm.